Personalized Skin Treatment System with AI-Driven Bacterial Extracts

A next-generation skin treatment system that leverages machine learning algorithms, skin microbiome analysis, and customized bacterial extracts to provide personalized solutions for sensitive skin and cutaneous neurogenic inflammation.

The original patent disclosed a novel bacterial extract for treating sensitive skin, but it had limitations in terms of individualized treatment and adaptability to varying skin profiles. The new inventive concept addresses these limitations by integrating AI-driven prediction models, skin microbiome analysis, and targeted delivery systems to create a more effective and personalized approach to skin treatment.

The system comprises a bacterial extract of a non-pathogenic Gram-negative bacterium belonging to the class Betaproteobacteria, subfamily Neisseriaceae, which is tailored to an individual's specific skin profile using machine learning algorithms and skin microbiome analysis. The system also includes a nanocarrier for targeted delivery to sensitive skin areas, which releases the bacterial extract in response to changes in skin pH. Additionally, a wearable device with a sensor for detecting changes in skin pH and a microcontroller for releasing the customized bacterial extract can be used to monitor skin health and provide real-time treatment.

The new claims introduce the concept of personalized skin treatment using AI-driven prediction models, skin microbiome analysis, and targeted delivery systems, which are not present in the original patent. The inventive step lies in the integration of these components to create a more effective and adaptable skin treatment system.

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, varying types of nanocarriers, or alternative sensors for detecting changes in skin pH. Additionally, the system could be adapted for use in treating other skin conditions, such as acne or rosacea.

The inventive concept has significant commercial potential in the cosmetics and dermatology industries, particularly in the growing market for personalized skin care and treatment. The system could be marketed as a premium product for individuals seeking tailored solutions for sensitive skin and cutaneous neurogenic inflammation.